Cancer BiologybioRxivPreprint
Bispecific antibody-drug conjugates targeting EGFR and LGR5 exert potent antitumor activity in colorectal cancer models
Peyton C. High, Maya G. Cappellino, Sean P. Sullivan…·Kendra S. Carmon
EGFR:LGR5 bispecific antibody-drug conjugates show strong antitumor effects and outperform other ADCs in colorectal cancer models.
1 citation